Literature DB >> 22138676

PAX2 in human kidney malformations and disease.

Lyndsay A Harshman1, Patrick D Brophy.   

Abstract

Human PAX2 mutations have been associated with abnormalities in the developing and adult kidney ranging from congenital abnormalities of the kidney and urinary tract (CAKUT) to oncogenic processes. Defining the relationship of PAX2 to human renal disease requires an appreciation of its fundamental role in renal development. Given the highly conserved nature of the PAX2 gene in vertebrates, it is not surprising that much of our understanding of PAX2 involvement in renal disease has been derived from animal models. The following review will outline the current evidence supporting involvement of PAX2 in the pathologic processes involving the kidney.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138676     DOI: 10.1007/s00467-011-2053-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  90 in total

Review 1.  Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.

Authors:  C Mrowka; A Schedl
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

2.  PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.

Authors:  Ayhan Ozcan; Qihui Zhai; Rehana Javed; Steven S Shen; Donna Coffey; Bhuvaneswari Krishnan; Luan D Truong
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

Review 3.  Diffuse mesangial sclerosis: a congenital glomerulopathy with nephrotic syndrome.

Authors:  R Habib; M C Gubler; C Antignac; M F Gagnadoux
Journal:  Adv Nephrol Necker Hosp       Date:  1993

4.  Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4.

Authors:  K Stark; S Vainio; G Vassileva; A P McMahon
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

5.  The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations.

Authors:  P J Winyard; R A Risdon; V R Sams; G R Dressler; A S Woolf
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 6.  Pax-2, kidney development, and oncogenesis.

Authors:  G R Dressler
Journal:  Med Pediatr Oncol       Date:  1996-11

Review 7.  The role of PAX2 in normal and abnormal development of the urinary tract.

Authors:  M R Eccles
Journal:  Pediatr Nephrol       Date:  1998-11       Impact factor: 3.714

8.  Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux.

Authors:  P Sanyanusin; L A Schimmenti; L A McNoe; T A Ward; M E Pierpont; M J Sullivan; W B Dobyns; M R Eccles
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

9.  Spatially and temporally restricted expression of Pax2 during murine neurogenesis.

Authors:  H O Nornes; G R Dressler; E W Knapik; U Deutsch; P Gruss
Journal:  Development       Date:  1990-08       Impact factor: 6.868

10.  Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development.

Authors:  A Schuchardt; V D'Agati; V Pachnis; F Costantini
Journal:  Development       Date:  1996-06       Impact factor: 6.868

View more
  17 in total

1.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

2.  PAX2 polymorphisms and congenital abnormalities of the kidney and urinary tract in a Brazilian pediatric population: evidence for a role in vesicoureteral reflux.

Authors:  Débora Marques de Miranda; Augusto César Soares Dos Santos Júnior; Geisilaine Soares Dos Reis; Izabella Silva Freitas; Thiago Guimarães Rosa Carvalho; Luiz Armando Cunha de Marco; Eduardo Araújo Oliveira; Ana Cristina Simões E Silva
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

3.  Mutations in PAX2 associate with adult-onset FSGS.

Authors:  Moumita Barua; Emilia Stellacci; Lorenzo Stella; Astrid Weins; Giulio Genovese; Valentina Muto; Viviana Caputo; Hakan R Toka; Victoria T Charoonratana; Marco Tartaglia; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

4.  Repair after nephron ablation reveals limitations of neonatal neonephrogenesis.

Authors:  Florian Tögel; M Todd Valerius; Benjamin S Freedman; Rossella Iatrino; Mor Grinstein; Joseph V Bonventre
Journal:  JCI Insight       Date:  2017-01-26

Review 5.  A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT).

Authors:  Vasikar Murugapoopathy; Indra R Gupta
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-18       Impact factor: 8.237

6.  DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.

Authors:  Nan Jia; Jieyu Wang; Qing Li; Xiang Tao; Kaikai Chang; Keqin Hua; Yinhua Yu; Kwong-Kwok Wong; Weiwei Feng
Journal:  Oncotarget       Date:  2016-12-20

Review 7.  The Utility of Human Kidney Organoids in Modeling Kidney Disease.

Authors:  Aneta Przepiorski; Amanda E Crunk; Eugenel B Espiritu; Neil A Hukriede; Alan J Davidson
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

8.  Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.

Authors:  Karen M Watters; Kenneth Bryan; Niamh H Foley; Maria Meehan; Raymond L Stallings
Journal:  BMC Cancer       Date:  2013-04-08       Impact factor: 4.430

9.  Diverse Renal Phenotypes Observed in a Single Family with a Genetic Mutation in Paired Box Protein 2.

Authors:  Yoichi Iwafuchi; Tetsuo Morioka; Takashi Morita; Toshio Yanagihara; Yuko Oyama; Naoya Morisada; Kazumoto Iijima; Ichiei Narita
Journal:  Case Rep Nephrol Dial       Date:  2016-04-14

10.  Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management.

Authors:  Jiwon Jung; Joo Hoon Lee; Young Seo Park; Go Hun Seo; Changwon Keum; Hee Gyung Kang; Hajeong Lee; Sang Koo Lee; Sang Taek Lee; Heeyeon Cho; Beom Hee Lee
Journal:  BMC Med Genomics       Date:  2021-07-03       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.